Ben Yong 4

What Happened

• Ben Yong, Chief Medical & Development Officer of BridgeBio Oncology (BBOT), had 1,047 shares of common stock withheld by the company to satisfy tax withholding obligations related to vested restricted stock units. The withholding was recorded as a disposition at $9.03 per share, for a total value of $9,454 on April 1, 2026. This was a tax-withholding transaction (routine), not an open-market sale.

Key Details

• Transaction date and price: 2026-04-01 at $9.03 per share
• Shares involved: 1,047 shares withheld (disposed) for taxes; total value ~$9,454
• Shares owned after transaction: Not specified in the provided filing excerpt
• Footnote: F1 — Shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units
• Filing timeliness: Form filed 2026-05-05 (about 34 days after the transaction), which appears to be a late filing

Context

• This was a tax-withholding (cashless retention) related to RSU vesting, a routine administrative disposition that does not necessarily indicate the insider's view on the company's stock. It is not an open-market sale or purchase.